Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 2
1974 11
1975 26
1976 47
1977 60
1978 79
1979 96
1980 74
1981 74
1982 80
1983 130
1984 84
1985 79
1986 106
1987 81
1988 67
1989 65
1990 74
1991 58
1992 74
1993 59
1994 47
1995 57
1996 48
1997 44
1998 51
1999 39
2000 41
2001 23
2002 23
2003 24
2004 30
2005 26
2006 33
2007 16
2008 25
2009 27
2010 17
2011 19
2012 22
2013 18
2014 29
2015 25
2016 12
2017 19
2018 16
2019 16
2020 17
2021 15
2022 18
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

2,180 results

Results by year

Filters applied: . Clear all
Page 1
A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
Kässner F, Hodder R, Bateman ED. Kässner F, et al. Drugs. 2004;64(15):1671-82. doi: 10.2165/00003495-200464150-00005. Drugs. 2004. PMID: 15257628 Review.
Berodual is a fixed combination of the anticholinergic agent ipratropium bromide (IB) and the beta2-adrenergic agonist fenoterol hydrobromide (FEN). IB/FEN has been available for the treatment of asthma and COPD in a pressurised metered dose inhaler (MDI) [pMDI] for …
Berodual is a fixed combination of the anticholinergic agent ipratropium bromide (IB) and the beta2-adrenergic agonist fenoterol h …
[Fenoterol].
Mohr K. Mohr K. Dtsch Med Wochenschr. 1994 Jun 3;119(22):813-4. doi: 10.1055/s-0029-1235064. Dtsch Med Wochenschr. 1994. PMID: 8205944 German. No abstract available.
Fenoterol hydrobromide delivered via HFA-MDI or CFC-MDI in patients with asthma: a safety and efficacy comparison.
Goldberg J, Böhning W, Schmidt P, Freund E. Goldberg J, et al. Respir Med. 2000 Oct;94(10):948-53. doi: 10.1053/rmed.2000.0864. Respir Med. 2000. PMID: 11059947 Free article. Clinical Trial.
The main objective of the study was to compare the long-term safety and tolerability of fenoterol hydrobromide delivered using a metered-dose inhaler formulated with the alternative propellant, hydrofluoroalkane 134a (HFA-MDI), with delivery using the currently avai …
The main objective of the study was to compare the long-term safety and tolerability of fenoterol hydrobromide delivered using …
Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma.
Heel RC, Brogden RN, Speight TM, Avery GS. Heel RC, et al. Drugs. 1978 Jan;15(1):3-32. doi: 10.2165/00003495-197815010-00002. Drugs. 1978. PMID: 342228 Review.
Fenoterol, the 4-hydroxyphenyl derivative of orciprenaline, is a resorcinol derivative with relatively high selectivity for beta2-adrenoceptors. ...The onset of maximum effect is less rapid than with isoprenaline but is longer lasting. About 60% of the eventual maximum res …
Fenoterol, the 4-hydroxyphenyl derivative of orciprenaline, is a resorcinol derivative with relatively high selectivity for beta2-adr …
Fenoterol and asthma deaths.
[No authors listed] [No authors listed] Drug Ther Bull. 1990 Dec 10;28(25):65-6. Drug Ther Bull. 1990. PMID: 2131236 Review. No abstract available.
Fenoterol.
Kawachi I. Kawachi I. N Z Med J. 1989 Sep 13;102(875):478. N Z Med J. 1989. PMID: 2779903 No abstract available.
Fenoterol: a beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects.
Svedmyr N. Svedmyr N. Pharmacotherapy. 1985 May-Jun;5(3):109-26. doi: 10.1002/j.1875-9114.1985.tb03409.x. Pharmacotherapy. 1985. PMID: 2991865 Review.
Fenoterol (hydroxyphenylorciprenaline) is chemically closely related to metaproterenol (orciprenaline). It has a higher bronchodilating potency than metaproterenol, albuterol (salbutamol in Europe) or terbutaline. The beta 2 selectivity of fenoterol at normal oral a …
Fenoterol (hydroxyphenylorciprenaline) is chemically closely related to metaproterenol (orciprenaline). It has a higher bronchodilati …
New enhanced spectrofluorimetric approach for picogram detection of Fenoterol hydrobromide through Von Pechman synthesis of coumarins.
Omar MA, Hammad MA, Awad M. Omar MA, et al. Spectrochim Acta A Mol Biomol Spectrosc. 2018 Nov 5;204:702-707. doi: 10.1016/j.saa.2018.06.108. Epub 2018 Jul 2. Spectrochim Acta A Mol Biomol Spectrosc. 2018. PMID: 29982162
A new, specific, precise and very sensitive spectrofluorimetric methodology has been established and approved for determination of Fenoterol hydrobromide (FEN) in its pharmaceutical forms and spiked plasma. The strategy utilized the phenolic nature of FEN and its ca …
A new, specific, precise and very sensitive spectrofluorimetric methodology has been established and approved for determination of Fenote …
Effect of fenoterol stereochemistry on the beta2 adrenergic receptor system: ligand-directed chiral recognition.
Jozwiak K, Plazinska A, Toll L, Jimenez L, Woo AY, Xiao RP, Wainer IW. Jozwiak K, et al. Chirality. 2011;23 Suppl 1(Suppl 1):E1-6. doi: 10.1002/chir.20963. Epub 2011 May 26. Chirality. 2011. PMID: 21618615 Free PMC article. Review.
The beta(2) adrenergic receptor (beta(2)-AR) is a model system for studying the ligand recognition process in G protein-coupled receptors. Fenoterol (FEN) is a beta(2)-AR selective agonist that has two centers of chirality and exists as four stereoisomers. ...
The beta(2) adrenergic receptor (beta(2)-AR) is a model system for studying the ligand recognition process in G protein-coupled receptors. …
Utility of Europium ion characteristic peak for quantitation of Fenoterol hydrobromide and Salmeterol xinafoate in different matrices; application to stability studies.
Omar MA, Hammad MA, Awad M. Omar MA, et al. Spectrochim Acta A Mol Biomol Spectrosc. 2019 Jun 15;217:182-189. doi: 10.1016/j.saa.2019.03.072. Epub 2019 Mar 25. Spectrochim Acta A Mol Biomol Spectrosc. 2019. PMID: 30933783
A simple selective luminescent dependent approach was established for quantitation of two selective beta(2) agonists namely; Fenoterol hydrobromide (FEN) and Salmeterol xinafoate (SAL). This approach utilizes the capability of the cited drugs to undergo a complexati …
A simple selective luminescent dependent approach was established for quantitation of two selective beta(2) agonists namely; Fenoterol …
2,180 results